Keenova Therapeutics plc
NONE
DELAYED 1 MONTH

12 insider filings · Latest: Jul 21, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 20, 2026May 22 12:59 AMSilver Point Capital L.P.10% Owner
Purchase
210,000$90.50$19.0M6,035,214(D)

View →

May 19, 2026May 22 12:59 AMSilver Point Capital L.P.10% Owner
Purchase
187,500$90.50$17.0M5,825,214(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 2, 2026Jun 4 8:14 PMSophia J. LangloisDirector
Option Exercise
2,685—3,984(D)

View →

Jun 2, 2026Jun 4 8:14 PMSophia J. LangloisDirector
Disposition
2,197—6,669(D)

View →

Jun 2, 2026Jun 4 8:13 PMScott HirschDirector
Option Exercise
2,685—3,984(D)

View →

Jun 2, 2026Jun 4 8:13 PMScott HirschDirector
Disposition
2,197—6,669(D)

View →

Jun 2, 2026Jun 4 8:12 PMPaul EfronDirector
Disposition
2,930—7,564(D)

View →

Jun 2, 2026Jun 4 8:12 PMPaul EfronDirector
Option Exercise
3,580—3,984(D)

View →

Jun 2, 2026Jun 4 8:12 PMKatina DortonDirector
Option Exercise
4,882—27,000(D)

View →

Jun 2, 2026Jun 4 8:11 PMLeslie E DonatoDirector
Option Exercise
4,882—3,984(D)

View →

Jun 2, 2026Jun 4 8:11 PMPaul BisaroDirector
Option Exercise
2,685—42,343(D)

View →

Jun 2, 2026Jun 4 8:11 PMPaul BisaroDirector
Disposition
2,197—45,028(D)

View →

Jun 2, 2026Jun 4 8:10 PMJon ZinmanDirector
Option Exercise
4,882—34,672(D)

View →

Jun 2, 2026Jun 4 8:10 PMMarc J YoskowitzDirector
Disposition
2,930—8,891(D)

View →

Jun 2, 2026Jun 4 8:10 PMMarc J YoskowitzDirector
Option Exercise
3,579—5,312(D)

View →